Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evelo Biosciences Inc (EVLO)
NASDAQ:EVLO
Evelo Biosciences (EVLO) Stock Price & Analysis
182 Followers
EVLO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.48 - $48.40
Previous Close$4.11
Volume17.21K
Average Volume (3M)603.36K
Market Cap
$78.54M
Enterprise ValueN/A
Total Cash (Recent Filing)$7.62M
Total Debt (Recent Filing)$50.48M
Price to Earnings (P/E)-0.2
Beta2.13
Next Earnings
Nov 02, 2023EPS Estimate
-$0.91Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.30
Shares Outstanding18,835,066
10 Day Avg. Volume113,708
30 Day Avg. Volume603,355
Standard Deviation0.42
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-1.50
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$10.00Price Target Upside139.81% Upside
Rating ConsensusHold
Number of Analyst Covering1
Evelo Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVLO FAQ
What was Evelo Biosciences Inc’s price range in the past 12 months?
Evelo Biosciences Inc lowest stock price was $0.48 and its highest was $48.40 in the past 12 months.
What is Evelo Biosciences Inc’s market cap?
Currently, no data Available
When is Evelo Biosciences Inc’s upcoming earnings report date?
Evelo Biosciences Inc’s upcoming earnings report date is Nov 02, 2023 which is in 35 days.
How were Evelo Biosciences Inc’s earnings last quarter?
Evelo Biosciences Inc released its earnings results on Aug 14, 2023. The company reported -$3.78 earnings per share for the quarter, missing the consensus estimate of -$3.263 by -$0.517.
Is Evelo Biosciences Inc overvalued?
According to Wall Street analysts Evelo Biosciences Inc’s price is currently Undervalued.
Does Evelo Biosciences Inc pay dividends?
Evelo Biosciences Inc does not currently pay dividends.
What is Evelo Biosciences Inc’s EPS estimate?
Evelo Biosciences Inc’s EPS estimate is -$0.91.
How many shares outstanding does Evelo Biosciences Inc have?
Evelo Biosciences Inc has 18,835,066 shares outstanding.
What happened to Evelo Biosciences Inc’s price movement after its last earnings report?
Evelo Biosciences Inc reported an EPS of -$3.78 in its last earnings report, missing expectations of -$3.263. Following the earnings report the stock price went up 28.628%.
Which hedge fund is a major shareholder of Evelo Biosciences Inc?
Among the largest hedge funds holding Evelo Biosciences Inc’s share is Flagship Pioneering Inc.. It holds Evelo Biosciences Inc’s shares valued at 8M.
---
Evelo Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.00 (139.81% Upside)
$10.00 (139.81% Upside)
Blogger Sentiment
Bullish
EVLO Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 10.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $12.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.18%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-81.40%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Evelo Biosciences Inc
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding EVLO
Vanguard Total Stock Market ETF
$691.06K
Fidelity Nasdaq Composite Index ETF
$27.17K
Up to five ETFs with an Outperform Smart Score that hold EVLO. The ETFs are listed according to market value of EVLO within the ETF
Aclaris Therapeutics
―
Aileron Therapeutics
―
Arvinas Holding Company
―
Bioxcel Therapeutics
―
---